GSEA enrichment analysis revealed that many signaling pathways were significantly enriched in the high-risk subgroup, including pathways related to metabolism and metabolic diseases, such as pyruvate metabolism, glycolysis gluconeogenesis, and insulin signaling pathways. Here, INS is linked to metabolic disease.